Literature DB >> 12789819

[A comparative validation of the scale CES-D, BDI, and HADS(d) in diagnosis of depressive disorders in general practice].

A V Andriushchenko, M Iu Drobizhev, A V Dobrovol'skiĭ.   

Abstract

To determine a most precise instrument for diagnostics of depression and a level of its severity, a comparative study of 3 questionnaires: Hospital Anxiety and Depression Scale (d) (HADS(d)), Beck Depression Inventory (BDI) and Center for Epidemiological Studies Depression scale (CED-D) was conducted in 148 patients (91 women, 57 men), aged 46.5 +/- 9.34 years. An analysis of sensitivity, specificity and predictive values of positive and negative results allowed to detect optimal cut off points, distinguishing depressive patients, as follows: = 18 for CES-D, = 12 for BDI, = 0.89 for HADS(d). For all scales, areas under receiver-operator characteristic (ROC) curve (0.97 +/- 0.02, 0.96 +/- 0.02 and 0.94 +/- 0.02, respectively) proved to be comparable. The optimal cut off points for distinct separation between patients with mild and severe depression were detected as = 26 for CES-D, = 20 for BDI, = 10 for HADS(d). The area under ROC curve for CES-D was higher (0.99 +/- 0.01) than those for BDI (0.86 +/- 0.04) and for HADS(d) (0.83 +/- 0.05). The data obtained reveal that the cut off points ascertained in the study reduce a chance of depression under diagnosis. All the scales could be recommended to interns for primary (screening) diagnostics of depression in routine medical care.

Entities:  

Mesh:

Year:  2003        PMID: 12789819

Source DB:  PubMed          Journal:  Zh Nevrol Psikhiatr Im S S Korsakova        ISSN: 1997-7298


  9 in total

1.  How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment.

Authors:  N Hermanns; B Kulzer; M Krichbaum; T Kubiak; T Haak
Journal:  Diabetologia       Date:  2006-01-24       Impact factor: 10.122

2.  Combined Racial and Gender Differences in the Long-Term Predictive Role of Education on Depressive Symptoms and Chronic Medical Conditions.

Authors:  Shervin Assari
Journal:  J Racial Ethn Health Disparities       Date:  2016-06-07

3.  Gender differences in the relationship between alcohol use and depressive symptoms in St. Petersburg, Russia.

Authors:  Weihai Zhan; Alla V Shaboltas; Roman V Skochilov; Andrei P Kozlov; Tatiana V Krasnoselskikh; Nadia Abdala
Journal:  J Addict Res Ther       Date:  2012

4.  Depression in myasthenia gravis: a heterogeneous and intriguing entity.

Authors:  Yury V Gavrilov; Tatjana M Alekseeva; Olga A Kreis; Philipp O Valko; Konrad P Weber; Yulia Valko
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

5.  Validation of the Spanish Center for Epidemiological Studies Depression and Zung Self-Rating Depression Scales: a comparative validation study.

Authors:  Paulo Ruiz-Grosso; Christian Loret de Mola; Johann M Vega-Dienstmaier; Jorge M Arevalo; Kristhy Chavez; Ana Vilela; Maria Lazo; Julio Huapaya
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

6.  Subjective Well-Being From a Just-World Perspective: A Multi-Dimensional Approach in a Student Sample.

Authors:  Sofya Nartova-Bochaver; Matthias Donat; Claudia Rüprich
Journal:  Front Psychol       Date:  2019-07-30

7.  The Authenticity Scale: Validation in Russian Culture.

Authors:  Sofya Nartova-Bochaver; Sofia Reznichenko; John Maltby
Journal:  Front Psychol       Date:  2021-01-13

8.  Validation of the 10-Item Connor-Davidson Resilience Scale: The Case of Russian Youth.

Authors:  Sofya Nartova-Bochaver; Aleksei Korneev; Konstantin Bochaver
Journal:  Front Psychiatry       Date:  2021-02-10       Impact factor: 4.157

9.  Association of Depression with Subclinical Coronary Atherosclerosis: a Systematic Review.

Authors:  Sher Ali Khan; Usman Shahzad; Muhammad Samsoor Zarak; Junaid Channa; Inamullah Khan; Muhammad Owais Abdul Ghani
Journal:  J Cardiovasc Transl Res       Date:  2020-03-20       Impact factor: 4.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.